Cell and Gene Therapy
Contract Manufacturing of Cell and Gene Therapy Products
The European Institute for Research and Development of Transplantation Strategies (EUFETS AG) specializes in services for innovative therapeutic approaches including the support of clients developing gene and cell therapies. The services include a broad spectrum from process development and validation up to the production of material for clinical trials as well as for the market. In addition, EUFETS can provide cell based in vitro safety and efficacy studies as well as support of clinical studies. Fresenius is the majority owner of the Institute.